1. Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets
Published:September 2011
No.Of Pages:372
Price:US $ 4850
Report Summary
* The global pharmaceutical contract manufacturing and contract research
organizations revenue reached at $196.5 billion in 2010, it will further grow to
$217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016,
increasing at a compound annual growth rate (CAGR) of 10.6%.
* Contract manufacturing of OTC and nutritional products worldwide reached at
$114.8 billion in 2010, it will further grow to $127.9 billion in 2011 and is projected
to reach at $214.5 billion by 2016, increasing at a compound annual growth rate
(CAGR) of 10.9%.
* Contract manufacturing of bulk and dosage form drugs worldwide reached at
$48.6 billion in 2010, it will further grow to $53.4 billion in 2011 and is projected to
reach at $86.3 billion by 2016, increasing at a compound annual growth rate
(CAGR) of 10.1%.
STUDY OBJECTIVE
The objective of BCC Research in conducting this study is to provide an overview of
the current situation and future capabilities of the global pharmaceutical contract
manufacturing, research, and packaging markets. The study provides a global as
well as a regionally specific market overview. The report emphasizes the current
and future outlook of the pharmaceutical contract manufacturing market, with a
comprehensive analysis of the overall pharmaceutical and biotechnology
outsourcing industry.
The current report discusses and outlines the current capabilities as well as the
needs of the pharmaceutical contract manufacturing, research, and packaging
markets. In addition, it discusses company and market strategies to further
enhance the market. The report includes the different types of contract
manufacturing and, more specifically, the services offered by global contract
manufacturers, researchers, and packagers. The report also discusses the methods
best used to identify an effective contract manufacturer as well as the advantages
of contract manufacturing and outsourcing. The report highlights the need for
project management, provides market forecasts for different aspects of contract
manufacturing specific to each region, and examines the role of market leaders in
the industry. Regulatory requirements and new developments in the market are
also discussed in the report.

2. The report encompasses the revenues gained from contract manufacturing in each
specific market and in each specific region. Sales analysis was performed on
specific categories of drugs and dosage forms including API/bulk drugs and solid,
liquid, and semisolid dosage forms. Sales analyses were also performed on
revenues gained from contract packaging and contract research. The sales figures
discussed are for the examined period of 2009 to 2011. Sales figures were also
forecast for the following 5-year period from 2011 through 2016.
Over-the-counter (OTC) drugs, nutritional drugs, and drug delivery products are
discussed in a separate section of this report.
Browse All Pharmaceuticals Market Research Reports
REASONS FOR DOING THIS STUDY
The majority of pharmaceutical companies are now using contract manufacturing,
research, and packaging services. To save costs and product development time
while simultaneously being effective, efficient, and productive, pharmaceutical
companies are relying on contract manufacturers to fulfill many basic as well as
specialized competencies. This study discusses the different types of contracting
companies, their roles, and the share of the market they claim. New developments
and new technologies warrant the issuing of this report, which is an important
resource for anyone analyzing the discussed markets.
Trends in outsourcing and new emerging markets for outsourcing are providing a
new look to the market and greater options to pharmaceutical companies. The
industry is seeing an increase in outsourcing as contract manufacturers,
researchers, and packagers provide cheaper options as well as region-specific
suppliers. The new state-of-the-art packaging facilities as well as expensive
research facilities and capabilities of research organizations are enhancing the
overall growth of the contract manufacturing industry. Contract manufacturers are
providing pharmaceutical companies with expertise in all forms that the companies
do not have available in-house.
INTENDED AUDIENCE
This study examines the areas of market growth in pharmaceuticals contract
manufacturing, research, and packaging from the point of view of manufacturers
and users. Strategic decision makers at biochemical and biotechnology companies,
physicians, pharmaceuticals and biopharmaceuticals companies, and related
research companies will find value in this study.
SCOPE OF THE STUDY
The scope of this study encompasses the contract manufacturing, research, and
packaging markets. BCC analyzes each market and its applications for contract

3. manufacturing by its need for outsourcing, regulatory environment, technology
involved, market projections, and market share. Technological issues include the
latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this
study. BCC conducted a comprehensive literature search, which included technical
newsletters and journals, and many other sources. Data were collected through
interviews and correspondence with various analytical, chemical, pharmaceutical,
and contracting experts. Market sizing estimates and projections were based on
estimates such as the current number of end users, potential end users, mergers
and acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were surveyed to obtain data for this study.
Included were manufacturers and end users of pharmaceuticals through contract
manufacturing and research. Data were gathered from various industry sources.
BCC spoke with officials and physicians within the industry, and consulted
newsletters, company literature, product literature, and a host of technical articles,
journals, indexes, and abstracts. Exhaustive investigations of databases by key
terminology were completed. In addition, data were compiled from current
financial, trade, and government sources.
Table Of Contents
CHAPTER ONE: INTRODUCTION
STUDY OBJECTIVE
REASONS FOR DOING THIS STUDY
INTENDED AUDIENCE
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER
CHAPTER TWO: SUMMARY
SUMMARY
SUMMARY TABLE GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND
CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2016 ($ BILLIONS)

4. SUMMARY FIGURE GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND
CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2009-2016 ($ BILLIONS)
CHAPTER THREE: OVERVIEW
DEFINITIONS
HISTORY OF OUTSOURCING
TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
CHAPTER FOUR: OVERVIEW OF CONTRACT MANUFACTURING
TYPES OF CONTRACT MANUFACTURERS
CONTRACT MANUFACTURING TRAITS
REQUIREMENT
ABILITY TO BE FLEXIBLE
CAPABILITIES WITHOUT COST
ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
TABLE 2 KEY ADVANTAGES OF CONTRACT MANUFACTURING
TABLE 3 KEY DISADVANTAGES OF CONTRACT MANUFACTURING
SELECTING A CONTRACT MANUFACTURER
TABLE 4 KEY FACTORS IN SELECTING A CONTRACT MANUFACTURER
ADDITIONAL FACTS ABOUT CONTRACT MANUFACTURING
LOCATION AND PROXIMITY
AFTER-SALES SUPPORT
CHAPTER FIVE: OVERVIEW OF CONTRACT RESEARCH
OVERVIEW OF CONTRACT RESEARCH
SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATIONS
TABLE 5 SERVICES OF CONTRACT RESEARCH ORGANIZATIONS
SELECTING A CONTRACT RESEARCH ORGANIZATION
TABLE 6 KEY CHARACTERISITCS IN SELECTING A CONTRACT RESEARCH
ORGANIZATION
RESEARCH PROVIDED BY CONTRACT RESEARCH ORGNIZATIONS
TABLE 7 TYPES OF RESEARCH PROVIDED BY CONTRACT RESEARCH
ORGANIZATIONS
CHAPTER SIX: OVERVIEW OF CONTRACT PACKAGING
NEEDING A CONTRACT PACKAGER
TABLE 8 REASONS BEHIND NEEDING A CONTRACT PACKAGER
SELECTING A CONTRACT PACKAGER
TABLE 9 KEY CHARACTERISTICS IN SELECTING A CONTRACT PACKAGER
HIRING A CONTRACT PACKAGER
TABLE 10 KEY STEPS IN HIRING A CONTRACT PACKAGER
TYPES OF PACKAGING
CHAPTER SEVEN: PROJECT MANAGEMENT
SPECIFICATIONS OF PROJECT MANAGEMENT
TABLE 11 STEPS OF PROJECT MANAGEMENT
PROCESSES OF PROJECT MANAGEMENT

5. TABLE 12 PROCESSES OF PROJECT MANAGEMENT
FACTORS INVOLVED
ROLE OF THE PROJECT MANAGER
TABLE 13 KEY RESPONSIBILITIES OF PROJECT MANAGERS
TECHNOLOGY TRANSFER
TABLE 14 TECHNOLOGY TRANSFER STEPS
CHAPTER EIGHT: REGULATORY ASPECTS
REGULATORY ASPECTS
TABLE 15 REGULATED FACTORS OF CMO’S AND CRO’S
TABLE 16 TITLE 21 CFR RULES ASSOCIATED WITH CONTRACT MANUFACTURING
WARNING LETTERS
TABLE 17 WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2010
TABLE 18 WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS, 2009
REGULATORY APPROVALS
TABLE 9 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, JANUARY THROUGH MARCH, 2011
TABLE 20 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2010
TABLE 21 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2009
CHAPTER NINE: INDUSTRY STRUCTURE FOR NORTH AMERICA
MARKET SHARE OF INDUSTRY LEADERS
CONTRACT MANUFACTURERS OF BULK DRUGS AND API’S
TABLE 22 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN NORTH AMERICA, 2010 (%)
FIGURE 1 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN NORTH AMERICA, 2010 (%)
CONTRACT MANUFACTURERS OF SOLID-DOSAGE FORMS
TABLE 23 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
FIGURE 2 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
NONSTERILE
TABLE 24 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
FIGURE 3 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
STERILE
TABLE 25 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
FIGURE 4 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS
TABLE 26 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES

6. PROVIDING SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
FIGURE 5 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, IN NORTH AMERICA, 2010 (%)
CONTRACT RESEARCH COMPANIES
TABLE 27 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH
AMERICA, 2010 (%)
FIGURE 6 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN NORTH
AMERICA, 2010 (%)
CONTRACT PACKAGING COMPANIES
TABLE 28 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH
AMERICA 2010 (%)
FIGURE 7 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN NORTH
AMERICA, 2010 (%)
CHAPTER TEN: INDUSTRY STRUCTURE FOR EUROPE
MARKET SHARE OF INDUSTRY LEADERS
CONTRACT MANUFACTURERS OF BULK DRUGS AND API’S
TABLE 29 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN EUROPE, 2010 (%)
FIGURE 8 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN EUROPE, 2010 (%)
CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
TABLE 30 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 9 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
NONSTERILE
TABLE 31 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 10 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
STERILE
TABLE 32 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 11 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN EUROPE, 2010 (%)
CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS
TABLE 33 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
FIGURE 12 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, IN EUROPE, 2010 (%)
CONTRACT RESEARCH COMPANIES
TABLE 34 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN EUROPE,
2010 (%)
FIGURE 13 MARKET SHARE OF CONTRACT RESEARCH COMPANIES, IN EUROPE,
2010 (%)

7. TABLE 35 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN EUROPE,
2010 (%)
FIGURE 14 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN EUROPE,
2010 (%)
CHAPTER ELEVEN: INDUSTRY STRUCTURE FOR EMERGING MARKETS
MARKET SHARE OF INDUSTRY LEADERS
CONTRACT MANUFACTURERS OF BULK DRUGS AND API’S
TABLE 36 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN REST OF WORLD, 2010 (%)
FIGURE 15 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/API’S, IN REST OF WORLD, 2010 (%)
CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS
TABLE 37 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, 2010 (%)
FIGURE 16 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, IN REST OF WORLD, 2010 (%)
CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS
NONSTERILE
TABLE 38 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010 (%)
FIGURE 17 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING NONSTERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010 (%)
STERILE
TABLE 39 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010 (%)
FIGURE 18 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING STERILE LIQUID DOSAGE FORMS, IN REST OF WORLD, 2010 (%)
CONTRACT MANUFACTURING OF SEMISOLID DOSAGE FORMS
TABLE 40 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, IN REST OF WORLD, 2010 (%)
FIGURE 19 MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, IN REST OF WORLD, 2010 (%)
CONTRACT RESEARCH COMPANIES
TABLE 41 MARKET SHARES OF CONTRACT RESEARCH COMPANIES, IN REST OF
WORLD, 2010 (%)
FIGURE 20 MARKET SHARES OF CONTRACT RESEARCH COMPANIES, IN REST OF
WORLD, 2010 (%)
CONTRACT PACKAGING COMPANIES
TABLE 42 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN REST OF
WORLD, 2010 (%)
FIGURE 21 MARKET SHARE OF CONTRACT PACKAGING COMPANIES, IN REST OF
WORLD, 2010 (%)
TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS
TABLE 43 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH
FIRMS TABLE 44 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY
PACKAGING TYPE

8. CHAPTER TWELVE: TECHNOLOGY TRANSFER
REASONS FOR TECHNOLOGY TRANSFER
CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER
TECHNOLOGY TRANSFER
STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER
TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER
CONFIDENTIAL DISCLOSURE AGREEMENT (CDA)
MATERIAL TRANSFER AGREEMENT (MTA)
ASSIGNMENT DEED
LICENSE AGREEMENT
CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS
CHARACTERISTICS OF A SUCCESSFUL PROJECT
CHAPTER THIRTEEN: NEW DEVELOPMENTS
LONZA
ABBOTT
HOSPIRA
COVIDIEN
OTHER
CHAPTER FOURTEEN: MARKET ANALYSIS FOR NORTH AMERICA
CONTRACT MANUFACTURING
CONTRACT MANUFACTURE OF BULK DRUGS/API’S
Market Overview
Market Revenue
TABLE 45 BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA,
THROUGH 2016 ($ BILLIONS)
FIGURE 22 BULK DRUG/API CONTRACT MANUFACTURING, FOR NORTH AMERICA,
2009-2016 ($ BILLIONS)
CONTRACT MANUFACTURE OF DOSAGE FORMULATIONS
Solid Dosage Formulations
Market Overview
Market Revenue
TABLE 46 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH
AMERICA, THROUGH 2016 ($ BILLIONS)
FIGURE 23 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH
AMERICA, 2009-2016 ($ BILLIONS)
Market by Formulation
Market Revenue
TABLE 47 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR NORTH AMERICA, THROUGH 2016 ($ BILLIONS)
FIGURE 24 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATIONS, FOR NORTH AMERICA, 2009-2016 ($ BILLIONS)
TABLE 48 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY
FORMULATION, FOR NORTH AMERICA, 2010 (%)
FIGURE 25 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES,
BY FORMULATIONS, FOR NORTH AMERICA, 2010 (%)

9. Liquid Dosage Formulation
Market Overview
Market Revenue
Nonsterile Formulations
TABLE 49 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR
NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 26 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING,
FOR NORTH AMERICA, 2009-2016 ($ MILLIONS)
Sterile Formulations
TABLE 50 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 27 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
Market by Formulation
Nonsterile Formulations
TABLE 51 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 28 LIQUID DOSAGE FORM (NON STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016 ($ MILLIONS)
TABLE 52 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARES BY FORMULATION, FOR NORTH AMERICA, 2010 (%)
FIGURE 29 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARES, BY FORMULATION, FOR NORTH AMERICA, 2010 (%)
Sterile Formulations
TABLE 53 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 30 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016 ($ MILLIONS)
TABLE 54 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010 (%)
FIGURE 31 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010 (%)
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS
Market Overview
Market Revenue
TABLE 55 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH
AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 32 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR NORTH
AMERICA, 2009-2016 ($ MILLIONS)
TABLE 56 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 33 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR NORTH AMERICA, 2009-2016 ($ MILLIONS)
TABLE 57 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010 (%)
FIGURE 34 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010 (%)

10. CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
Market Overview
TABLE 58 CONTRACTING COMPANIES PROVIDING DRUGDELIVERY
SYSTEMS
Market Revenue
TABLE 59 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016 ($ BILLIONS)
FIGURE 35 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR NORTH AMERICA, THROUGH 2016 ($ BILLIONS)
Market by Formulation
TABLE 60 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY
CONTRACT MANUFACTURING REVENUE, BY FORMULATION, THROUGH 2016 ($
MILLIONS)
FIGURE 36 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY
CONTRACT MANUFACTURING REVENUE, BY FORMULATIONS, 2009-2016 ($
MILLIONS)
Market Share
TABLE 61 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY
CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATION, 2010 (%)
FIGURE 37 ADVANCED DRUG DELIVERY SYSTEMS FOR NORTH AMERICA, BY
CONTRACT MANUFACTURING MARKET SHARE, BY FORMULATIONS, 2010 (%)
CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
Market Overview
Market Revenue
TABLE 62 OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY
CONTRACT MANUFACTURING, THROUGH 2016 ($ BILLIONS)
FIGURE 38 OTC AND NUTRITIONAL PRODUCT REVENUE FOR NORTH AMERICA BY
CONTRACT MANUFACTURING, 2009-2016 ($ BILLIONS)
Market by Formulation
TABLE 63 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE BY FORMULATION FOR NORTH AMERICA, THROUGH 2016 ($ BILLIONS)
FIGURE 39 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR NORTH AMERICA, 2009-2016 ($ BILLIONS)
Market Shares
TABLE 64 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR NORTH AMERICA, 2010 (%)
FIGURE 40 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATIONS, FOR NORTH AMERICA, 2010 (%)
CONTRACT RESEARCH
MARKET OVERVIEW
Partnerships
Expansions of Facilities
MARKET REVENUE
TABLE 65 CONTRACT RESEARCH REVENUE FOR NORTH AMERICA, THROUGH 2016
($ BILLIONS)
FIGURE 41 CONTRACT RESEARCH REVENUE, FOR NORTH AMERICA, 2009-2016 ($
BILLIONS)

11. Market by Discipline
TABLE 66 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA,
THROUGH 2016 ($ BILLIONS)
FIGURE 42 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA,
2009-2016 ($ BILLIONS)
Market Shares by Discipline
TABLE 67 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH
AMERICA, 2010 (%)
FIGURE 43 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR NORTH
AMERICA, 2010 (%)
CONTRACT PACKAGING
MARKET OVERVIEW
Market Revenue
TABLE 68 CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, THROUGH
2016 ($ BILLIONS)
FIGURE 44 CONTRACT PACKAGING REVENUE, FOR NORTH AMERICA, 2009-2016 ($
BILLIONS)
Market by Package Type
TABLE 69 CONTRACT PACKAGING REVENUE BY TYPE, FOR NORTH AMERICA,
THROUGH 2016 ($ MILLIONS)
FIGURE 45 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR NORTH AMERICA,
2009-2016 ($ MILLIONS)
Market Share by Type
TABLE 70 CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH AMERICA,
2010 (%)
FIGURE 46 CONTRACT PACKAGING MARKET SHARE, BY TYPE, FOR NORTH
AMERICA, 2010 (%)
CHAPTER FIFTEEN: MARKET ANALYSIS FOR EUROPE
CONTRACT MANUFACTURING
CONTRACT MANUFACTURE OF BULK DRUGS/API’S
Market Overview
Market Revenue
TABLE 71 BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOR EUROPE,
THROUGH 2016 ($ BILLIONS)
FIGURE 47 BULK DRUG/API CONTRACT MANUFACTURING REVENUE, FOR EUROPE,
2009-2016 ($ BILLIONS)
CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS
Solid Dosage Formulations
Market Overview
Market Revenue
TABLE 72 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE,
THROUGH 2016 ($ BILLIONS)
FIGURE 48 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE,
2009- 2016 ($ BILLIONS)
Market by Formulation
Market Revenue

12. TABLE 73 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 49 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATIONS, FOR EUROPE, 2009-2016 ($ BILLIONS)
TABLE 74 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES, BY
FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 50 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES,
BY FORMULATIONS, FOR EUROPE, 2010 (%)
Liquid Dosage Formulation
Market Overview
Market Revenue
Nonsterile Formulations
TABLE 75 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING, FOR
EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 51 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING,
FOR EUROPE, 2009-2016 ($ MILLIONS)
Sterile Formulations
TABLE 76 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 52 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
EUROPE, 2009-2016 ($ MILLIONS)
Market by Formulation
Nonsterile Formulations
TABLE 77 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 53 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016 ($ MILLIONS)
TABLE 78 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARES, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 54 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARES, BY FORMULATIONS, FOR EUROPE, 2010 (%)
Sterile Formulations
TABLE 79 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 55 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, 2009-2016 ($ MILLIONS)
TABLE 80 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 56 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS
Market Overview
Market Revenue
TABLE 81 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE,
THROUGH 2016 ($ MILLIONS)
FIGURE 57 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR EUROPE,
2009-2016 ($ MILLIONS)

13. TABLE 82 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 58 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATIONS, FOR EUROPE, 2009-2016 ($ MILLIONS)
TABLE 83 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 59 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)
CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
Market Overview
TABLE 84 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS
Market Revenue
TABLE 85 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 60 ADVANCED DRUG DELIVERY SYSTEMS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016 ($ BILLIONS)
Market by Formulation
TABLE 86 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 61 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016 ($ MILLIONS)
Market Share
TABLE 87 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 62 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)
CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
Market Revenue
TABLE 88 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 63 OTC AND NUTRITIONAL PRODUCTS REVENUE, BY CONTRACT
MANUFACTURING, FOR EUROPE, 2009-2016 ($ BILLIONS)
Market by Formulation
TABLE 89 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 64 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR EUROPE, 2009-2016 ($ BILLIONS)
Market Shares
TABLE 90 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR EUROPE, 2010 (%)
FIGURE 65 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATIONS, FOR EUROPE, 2010 (%)
CONTRACT RESEARCH
MARKET OVERVIEW
Partnerships
Expansions of Facilities
Market Revenue

14. TABLE 91 CONTRACT RESEARCH REVENUE, FOR EUROPE, THROUGH 2016 ($
BILLIONS)
FIGURE 66 CONTRACT RESEARCH REVENUE, FOR EUROPE, 2009-2016 ($
BILLIONS)
Market by Discipline
TABLE 92 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE,
THROUGH 2016 ($ MILLIONS)
FIGURE 67 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE, 2009-
2016 ($ MILLIONS)
Market Share by Discipline
TABLE 93 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR EUROPE,
2010 (%)
FIGURE 68 CONTRACT RESEARCH MARKET SHARE, BY DISCIPLINE, FOR EUROPE,
2010 (%)
CONTRACT PACKAGING
MARKET OVERVIEW
Market Revenue
TABLE 94 CONTRACT PACKAGING REVENUE, FOR EUROPE, THROUGH 2016 ($
BILLIONS)
FIGURE 69 CONTRACT PACKAGING REVENUE, FOR EUROPE, 2009-2016 ($
BILLIONS)
Market by Package Type
TABLE 95 CONTRACT PACKAGING REVENUE BY TYPE, FOR EUROPE, THROUGH
2016 ($ MILLIONS)
FIGURE 70 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR EUROPE, 2009-
2016 ($ BILLIONS)
Market Share by Type
TABLE 96 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE, 2010
(%)
FIGURE 71 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR EUROPE, 2010
(%)
CHAPTER SIXTEEN: MARKET ANALYSIS FOR REST OF WORLD/EMERGING
MARKETS
CONTRACT MANUFACTURING
CONTRACT MANUFACTURE OF BULK DRUGS/API’S
Market Overview
Market Revenue
TABLE 97 REST OF WORLD BULK DRUG/API’S CONTRACT MANUFACTURING
REVENUE, THROUGH 2016 ($ BILLIONS)
FIGURE 72 REST OF WORLD BULK DRUG/API’S CONTRACT MANUFACTURING
REVENUE, 2009-2016 ($ BILLIONS)
CONTRACT MANUFACTURE OF ORAL DOSAGE
FORMULATIONS
Solid Dosage Formulations
Market Overview
Market Revenue

15. TABLE 98 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF
WORLD, THROUGH 2016 ($ BILLIONS)
FIGURE 73 SOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF
WORLD, 2009-2016 ($ BILLIONS)
Market by Formulation
Market Revenue
TABLE 99 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS)
FIGURE 74 SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE, BY
FORMULATION, FOR REST OF WORLD, 2009-2016 ($ BILLIONS)
TABLE 100 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
FORMULATION, FOR REST OF WORLD, 2010 (%)
FIGURE 75 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE BY
FORMULATION, FOR REST OF WORLD, 2010 (%)
Liquid Dosage Formulation
Market Overview
Market Revenue
Nonsterile Formulations
TABLE 101 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
FOR REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 76 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
FOR REST OF WORLD, 2009-2016 ($ MILLIONS)
Sterile Formulations
TABLE 102 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 77 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING, FOR
REST OF WORLD, 2009-2016 ($ MILLIONS)
Market by Formulation
Nonsterile Formulations
TABLE 103 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 78 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, 2009-2016 ($ MILLIONS)
TABLE 104 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010 (%)
FIGURE 79 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010 (%)
Sterile Formulations
TABLE 105 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE BY FORMULATION FOR REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 80 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
REVENUE BY FORMULATION, FOR REST OF WORLD, 2009-2016 ($ MILLIONS)
TABLE 106 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010 (%)
FIGURE 81 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010 (%)
CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS

16. Market Overview
Market Revenue
TABLE 107 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF
WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 82 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING, FOR REST OF
WORLD, 2009-2016 ($ MILLIONS)
Market by Formulation
TABLE 108 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY
FORMULATION, FOR REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 83 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY
FORMULATION, FOR REST OF WORLD, 2009-2016 ($ MILLIONS)
TABLE 109 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE BY FORMULATION, FOR REST OF WORLD, 2010 (%)
FIGURE 84 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE BY FORMULATION, FOR REST OF WORLD, 2010 (%)
CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS
Market Overview
TABLE 110 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS IN
ROW
TABLE 111 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS)
FIGURE 85 ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS)
Market by Formulation
TABLE 112 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 86 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, 2009-2016 ($ MILLIONS)
Market Share
TABLE 113 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010 (%)
FIGURE 87 ADVANCED DRUG DELIVERY SYSTEMS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010 (%)
CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS
Market Revenue
TABLE 114 OTC AND NUTRITIONAL PRODUCTS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS)
FIGURE 88 OTC AND NUTRITIONAL PRODUCTS REVENUE BY CONTRACT
MANUFACTURING, FOR REST OF WORLD, 2009-2016 ($ BILLIONS)
TABLE 115 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATION, FOR REST OF WORLD, THROUGH 2016 ($ BILLIONS)
FIGURE 89 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
REVENUE, BY FORMULATIONS, FOR REST OF WORLD, 2009-2016 ($ BILLIONS)
Market Shares
TABLE 116 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING
MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2010 (%)
FIGURE 90 OTC AND NUTRITIONAL PRODUCTS BY CONTRACT MANUFACTURING

17. MARKET SHARE, BY FORMULATION, FOR REST OF WORLD, 2009-2016 (%)
CONTRACT RESEARCH
MARKET OVERVIEW
Partnerships
Expansions of Facilities
Market Revenue
TABLE 117 CONTRACT RESEARCH REVENUE FOR REST OF WORLD, THROUGH 2016
($ BILLIONS)
FIGURE 91 CONTRACT RESEARCH REVENUE FOR REST OF WORLD, 2009-2016 ($
BILLIONS)
Market by Discipline
TABLE 118 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR REST OF WORLD,
THROUGH 2016 ($ BILLIONS)
FIGURE 92 CONTRACT RESEARCH REVENUE BY DISCIPLINE, FOR REST OF WORLD,
2009-2016 ($ BILLIONS)
Market Shares by Discipline
TABLE 119 CONTRACT RESEARCH MARKET SHARE BY DISCIPLINE, FOR REST OF
WORLD, 2010 (%)
FIGURE 93 CONTRACT RESEARCH MARKET SHARE BY DISCIPLINE, FOR REST OF
WORLD, 2010 (%)
CONTRACT PACKAGING
MARKET OVERVIEW
TABLE 120 CONTRACT PACKAGING REVENUE, FOR REST OF WORLD, THROUGH
2016 ($ BILLIONS)
FIGURE 94 CONTRACT PACKAGING REVENUE, FOR REST OF WORLD, 2009-2016 ($
BILLIONS)
Market by Package Type
Market Revenue
TABLE 121 CONTRACT PACKAGING REVENUE BY TYPE, FOR REST OF WORLD,
THROUGH 2016 ($ MILLIONS)
FIGURE 95 CONTRACT RESEARCH REVENUE BY DISCIPLINE FOR REST OF WORLD,
THROUGH 2016 ($ MILLIONS)
Market Share by Type
TABLE 122 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR REST OF WORLD,
2010 (%)
FIGURE 96 CONTRACT PACKAGING MARKET SHARE BY TYPE, FOR REST OF WORLD,
2010 (%)
CHAPTER SEVENTEEN: MARKET SHARE BY REGION
MARKET SHARE OF CONTRACT MANUFACTURED API’S
TABLE 123 BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010 (%)
FIGURE 97 BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED SOLID DOSAGE FORMS
TABLE 124 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010 (%)

18. FIGURE 98 SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED LIQUID DOSAGE FORMULATIONS
NONSTERILE FORMULATIONS
TABLE 125 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
FIGURE 99 LIQUID DOSAGE FORM (NONSTERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
STERILE FORMULATIONS
TABLE 126 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
FIGURE 100 LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED SEMISOLID
DOSAGE FORMULATIONS
TABLE 127 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARES, BY REGION, 2010 (%)
FIGURE 101 SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET
SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED ADVANCED DRUG DELIVERY
PRODUCTS
TABLE 128 DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010 (%)
FIGURE 102 DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARE, BY
REGION, 2010 (%)
MARKET SHARE OF CONTRACT MANUFACTURED OTC AND NUTRITIONAL
PRODUCTS
TABLE 129 OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
FIGURE 103 OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING
MARKET SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT RESEARCH
TABLE 130 CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010 (%)
FIGURE 104 CONTRACT RESEARCH MARKET SHARE, BY REGION, 2010 (%)
MARKET SHARE OF CONTRACT PACKAGING
TABLE 131 CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010 (%)
FIGURE 105 CONTRACT PACKAGING MARKET SHARE, BY REGION, 2010 (%)
CHAPTER EIGHTEEN: CONTRACT MANUFACTURING APPLICATIONS FOR
NORTH AMERICAN MARKETS
CARDIOVASCULAR DRUGS
MARKET REVENUE
TABLE 132 REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR
DRUGS, IN NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 106 REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR
DRUGS, IN NORTH AMERICA, 2009-2016 ($ MILLIONS)
REPRODUCTIVE DRUG MARKET

19. MARKET REVENUE
TABLE 133 REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE
DRUGS, IN NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 107 REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE
DRUGS, IN NORTH AMERICA, 2009-2016 ($ MILLIONS)
ONCOLOGY DRUG MARKET
MARKET REVENUE
TABLE 134 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS,
IN NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 108 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS,
IN NORTH AMERICA, 2009-2016 ($ MILLIONS)
ANALGESICS MARKET
MARKET REVENUE
TABLE 135 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN
NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 109 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN
NORTH AMERICA, 2009-2016 ($ MILLIONS)
MARKET REVENUE
TABLE 136 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN
NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 110 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN
NORTH AMERICA, 2009-2016 ($ MILLIONS)
ANTIBIOTICS MARKET
MARKET REVENUE
TABLE 137 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN
NORTH AMERICA, THROUGH 2016 ($ MILLIONS)
FIGURE 111 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN
NORTH AMERICA, 2009-2016 ($ MILLIONS)
MARKETS FOR OTHER DRUGS
MARKET REVENUE
TABLE 138 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN
NORTH AMERICA, THROUGH 2016 ($ BILLIONS)
FIGURE 112 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN
NORTH AMERICA, 2009-2016 ($ BILLIONS)
CHAPTER NINETEEN: CONTRACT MANUFACTURING APPLICATIONS FOR
EUROPEAN MARKETS
CARDIOVASCULAR DRUGS
MARKET REVENUE
TABLE 139 REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR
DRUGS, IN EUROPE, THROUGH 2016 ($MILLIONS)
FIGURE 113 REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR
DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)
REPRODUCTIVE DRUG MARKET
MARKET REVENUE
TABLE 140 REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE
DRUGS, IN EUROPE, THROUGH 2016 ($ MILLIONS)

20. FIGURE 114 REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE
DRUGS, IN EUROPE, 2009-2016 ($ MILLIONS)
ONCOLOGY DRUG MARKET
MARKET REVENUE
TABLE 141 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS,
IN EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 115 REVENUE FROM CONTRACT MANUFACTURERS OF ONCOLOGY DRUGS,
IN EUROPE, 2009-2016 ($ MILLIONS)
ANALGESICS MARKET
MARKET REVENUE
TABLE 142 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN
EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 116 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN
EUROPE, 2009-2016 ($ MILLIONS)
ANTIVIRAL DRUG MARKET
MARKET REVENUE
TABLE 143 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN
EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 117 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN
EUROPE, 2009-2016 ($ MILLIONS)
ANTIBIOTICS MARKET
MARKET REVENUE
TABLE 144 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN
EUROPE, THROUGH 2016 ($ MILLIONS)
FIGURE 118 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN
EUROPE, 2009-2016 ($ MILLIONS)
MARKETS FOR OTHER DRUGS
MARKET REVENUE
TABLE 145 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN
EUROPE, THROUGH 2016 ($ BILLIONS)
FIGURE 119 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN
EUROPE, 2009-2016 ($ BILLIONS)
CHAPTER TWENTY: CONTRACT MANUFACTURING APPLICATIONS FOR REST
OF THE WORLD (ROW)
CARDIOVASCULAR DRUGS
MARKET REVENUE
TABLE 146 REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR
DRUGS, IN REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 120 REVENUE FROM CONTRACT MANUFACTURERS OF CARDIOVASCULAR
DRUGS, IN REST OF WORLD, 2009-2016 ($ MILLIONS)
REPRODUCTIVE DRUG MARKET
MARKET REVENUE
TABLE 147 REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE
DRUGS, IN REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 121 REVENUE FROM CONTRACT MANUFACTURERS OF REPRODUCTIVE
DRUGS, IN REST OF WORLD, 2009-2016 ($ MILLIONS)

21. ONCOLOGY DRUG MARKET
MARKET REVENUE
TABLE 148 REVENUE FROM CONTRACT MANUFACTURERS OF DRUGS USED IN
ONCOLOGY, IN REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 122 REVENUE FROM CONTRACT MANUFACTURERS OF DRUGS USED IN
ONCOLOGY, IN REST OF WORLD, 2009-2016 ($ MILLIONS)
ANALGESICS MARKET
MARKET REVENUE
TABLE 149 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN
REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 123 REVENUE FROM CONTRACT MANUFACTURERS OF ANALGESICS, IN
REST OF WORLD, 2009-2016 ($ MILLIONS)
ANTIVIRAL DRUG MARKET
MARKET REVENUE
TABLE 150 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN REST
OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 124 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIVIRALS, IN
REST OF WORLD, 2009-2016 ($ MILLIONS)
ANTIBIOTICS MARKET
MARKET REVENUE
TABLE 151 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN
REST OF WORLD, THROUGH 2016 ($ MILLIONS)
FIGURE 125 REVENUE FROM CONTRACT MANUFACTURERS OF ANTIBIOTICS, IN
REST OF WORLD, 2009-2016 ($ MILLIONS)
MARKETS FOR OTHER DRUGS
MARKET REVENUE
TABLE 152 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN
REST OF WORLD, THROUGH 2016 ($ BILLIONS)
FIGURE 126 REVENUE FROM CONTRACT MANUFACTURERS OF OTHER DRUGS, IN
REST OF WORLD, 2009-2016 ($ BILLIONS)
CHAPTER TWENTY-ONE: PATENT ANALYSIS
PATENTS BY YEAR
TABLE 153 NUMBER OF SIGNIFICANT PATENTS, BY YEAR, 2009-2011
FIGURE 127 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011
FIGURE 128 NUMBER OF PATENTS, BY YEAR, 2009-MAY 31, 2011 (%)
PATENTS BY COMPANY
TABLE 154 NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
FIGURE 129 NUMBER OF U.S. PATENTS, BY COMPANY, 2009-2011
PATENTS BY COUNTRY
TABLE 155 NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
FIGURE 130 NUMBER OF U.S. PATENTS, BY COUNTRY, 1/1/2009 TO 5/31/2011
TABLE 156 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011 (%)
FIGURE 131 PATENT SHARES, BY COUNTRY, 1/1/2009 TO 5/31/2011 (%)
PATENTS BY EMPHASIS
TABLE 157 PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011
FIGURE 132 NUMBER OF U.S. PATENTS, BY EMPHASIS, 1/1/2009 TO 5/31/2011

22. CHAPTER TWENTY-TWO: CURRENT ENVIRONMENT
SITUATION OF THE NORTH AMERICAN CONTRACTING MARKETS
CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
CONTRACT RESEARCH
CONTRACT PACKAGING
SITUATION OF THE EUROPEAN CONTRACTING MARKET
CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
CONTRACT RESEARCH
CONTRACT PACKAGING
SITUATION OF THE ROW CONTRACTING MARKET
CONTRACT MANUFACTURING OF API AND DOSAGE FORMS
CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS
CONTRACT RESEARCH
CONTRACT PACKAGING
OPPORTUNITIES AND CHALLENGES OF THE CURRENT CONTRACT MANUFACTURING
INDUSTRY
CHAPTER TWENTY-THREE: COMPANY PROFILES
AAI PHARMA, INC.
ABBOTT LABORATORIES
AEROGEN LTD.
ALKERMES
ALTHEA TECHNOLOGIES
AMCOR
AMERISOURCE BERGEN CORPORATION
AMPAC FINE CHEMICALS
ALBANY MOLECULAR RESEARCH INC. (AMRI)
AP PHARMA INC.
APTUIT INC.
ARADIGM CORPORATION
BASF SE
BAXTER HEALTHCARE
BCM/BOOTS MANUFACTURING
BOEHRINGER INGELHEIM
BRISTOL-MYERS SQUIBB
CAMBREX CORPORATION
CANGENE CORPORATION
CATALENT PHARMA SOLUTIONS
CEDARBURG HAUSER PHARMACEUTICALS INC.
CENEXI
CHARLES RIVER LABORATORIES
CHEMBRIDGE CORP.
CLEARSTONE CENTRAL LABORATORIES
CONFAB LABORATORIES

23. COVANCE INC.
COVIDIEN
CONTRACT PHARMACEUTICALS LIMITED
CORDEN PHARMA SWITZERLAND LLC
DAVOS PHARMA
DECODE GENETICS
DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
DOW CHEMICAL
DPT LABORATORIES INC.
DR. REDDY’S LABORATORIES
DSM PHARMACEUTICAL PRODUCTS
FUJIFILM DIOSYNTH BIOTECHNOLOGY
ELAN DRUG TECHNOLOGIES
EVOTEC AG
FULCRUM PHARMA PLC
GIRINDUS AG
GLAXOSMITHKLINE
HOSPIRA
HAUPT PHARMA AG
HOVIONE S.A
ICON PLC
INC RESEARCH, INC.
JUBILANT LIFESCIENCES
KENDLE INTERNATIONAL INC.
KP PHARMACEUTICAL TECHNOLOGIES INC.
K.V. PHARMACEUTICAL CO.
LIGAND PHARMACEUTICALS, INC.
LONZA GROUP
LYNE LABORATORIES
MERCK / MSD BIOMANUFACTURING NETWORK
MIKART INC
NEXTPHARMA TECHNOLOGIES
NORWICH PHARMACEUTICALS
NOVAVAX, INC.
OMNICARE CLINICAL RESEARCH
PAREXEL INTERNATIONAL CORPORATION
PATHEON INC.
PERRIGO COMPANY
PFIZER (KING PHARMACEUTICALS)
PIRAMAL HEALTHCARE LIMITED
PPD
PRA INTERNATIONAL
QUINTILES
RANBAXY
REGIS TECHNOLOGIES, INC.
SKYEPHARMA
TALECRIS BIOTHERAPEUTICS INC.

24. VETTER PHARMA INTERNATIONAL GMBH
WOCKHARDT LIMITED
WUXI APP TEC
XCELLEREX LLC
ZACH SYSTEM S.P.A
APPENDIX I: ABBREVIATIONS
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and
in-depth market research studies & analysis of over 5000 micro markets. We
provide 24/7 online and offline support to our customers. Get in touch with us for
your needs of market research reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page:
http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit our Market Research Blog